Munich Re’s updated epidemic product gaining interest but high cost a hurdle

Munich Re – Coronavirus

Munich Re is out in the market with an updated version of its Epidemic Risk Solutions (ERS) offering, with the platform seeing plenty of interest in the Covid-19 fallout although sources said take-up is not thought to be high because of the prices being quoted.

Want to read this article?

Subscribe for FULL access to this article - and ALL our premium content

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey
Commercial director
Email: spencer.halladey@wbmediagroup.com
Tel: +44 (0) 203 934 6687

Andy Stone
Sales manager
Email: andy.stone@wbmediagroup.com
Tel: +44 (0) 203 934 6684

Subscribers get access to:

  • Full web access to all content
  • Regular breaking news/analysis by email on all critical issues
  • Two daily round-ups of the day’s news
  • Opinion from market thought-leaders and exclusive data on the industry
  • Control over the content you receive - and WHEN you receive it
  • Access to The Insurer App
  • Discounted subscriber prices for all our events
  • Dedicated account manager to ensure you receive the best value for money 

If you are a subscriber you can SIGN IN now for FULL access